Lundbeck

Lundbeck is a global pharmaceutical company specializing in the development and manufacture of products for the treatment of central nervous system disorders. Founded in 1915, the company is headquartered in Valby, Denmark, with locations in various countries, including Paramus, New Jersey, United States, Tokyo, Japan, and United Kingdom. The company operates as an Aktieselskab, a legal form in Denmark.

Employing around 5,500 people worldwide, Lundbeck is active in the fields of pharmaceuticals, drug discovery, biomedical engineering, and engineering. Their primary focus is on central nervous system disorders and treatment, which includes diseases like depression, schizophrenia, Parkinson's disease, and Alzheimer's disease.

The company is listed on the Nasdaq Copenhagen stock exchange under the stock symbol "LUN". Lundbeck is part of a competitive landscape with other notable industry players, such as Novozymes A/S and Vianex S.A.. As an active organization, Lundbeck continually expands and maintains its global presence, particularly within the growing pharmaceutical industry.